NEW YORK, March 2, 2026 /PRNewswire/ -- Cresilon announced its revolutionary hemostatic gel TRAUMAGEL ® has received an Innovative Technology contract from Vizient ® the nation's largest ...

(Reuters) - The U.S. Food and Drug Administration has cleared Cresilon's gel to quickly control bleeding, the privately held company said on Thursday, potentially giving emergency medical technicians ...

NEW YORK, March 25, 2026 /PRNewswire/ -- Cresilon has been named to Fast Company's World's 50 Most Innovative Companies of 2026. The company ranked No. 1 in the medical devices category and No. 46 ...

NEW YORK, March 12, 2026 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced that a retrospective ...

(MENAFN- PR Newswire) Hemostatic gel designed to control moderate to severe bleeding in seconds and save lives NEW YORK, Aug. 15, 2024 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based ...

VETIGEL, a revolutionary plant-based hemostatic gel that instantly stops and controls bleeding, is now available for veterinarian surgeons across Canada through McCarthy Vet. The agreement with ...

Biotechnology company Cresilon has more than doubled its U.S. headquarters and lab space at Brooklyn’s Industry City. “Industry City’s partnership over the past decade has played a critical role in ...

Company behind groundbreaking hemostatic technology launches animal philanthropy program at a time when nearly 30% of U.S. pet owners experience barriers to veterinary care Cresilon launches program ...

NEW YORK, Aug. 15, 2024 /CNW/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has received U.S. Food and ...